Further, despite the clear evidence of clonal CD8+ T cell expansion within the TIME extending out to d29 in some of our patients, the known lack of durable tumor responses to BRAF/MEKi, especially once treatment is stopped, suggests that this clonal expansion does not persist and is insufficient to eliminate the last tumor cell. Here, CD8A is linked to neoplasm.